X0708 D LIVE 0001420108 Glucose Health, Inc. 609 SW 8TH STREET, SUITE 600 BENTONVILLE AR ARKANSAS 72712 479-802-3827 DELAWARE Bio-Solutions Corp. Corporation true Mark Schaftlein 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director CEO and Director of Issuer Marc Hatch 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Executive Officer Chief Operating Officer and Chief Financial Officer of Issuer Chris Jemapete 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Edmund Burke 609 SW 8th Street Suite 600 Bentonville AR ARKANSAS 72717 Director Manufacturing $1 - $1,000,000 06b false 2026-06-25 false true true true Investment Units. Each Unit consists of one share of common stock and warrant to purchase one share of common stock 0ver 5 year term at $0.60 per shares false 60000 120000 60000 60000 false 1 0 0 0 true false Glucose Health, Inc. /s/ Mark Schaftlein Mark Schaftlein CEO 2026-07-07